- Funding Opportunities
- Research Areas
- Dynamic Brain Circuits and Connections in Health and Disease
- Core facilities
- Research administration services
- DMCBH Membership
- News & Events
- Brain Matters Newsletter
- Neuroscience Research Colloquium
You are hereNewsroom
DMCBH recruits highest number of participants for international MS study
The Djavad Mowafaghian Centre for Brain Health has topped 193 research sites around the world having recruited the most participants for an international clinical trial investigating the efficacy of a new multiple sclerosis (MS) drug called ocrelizumab.
“A good centre could maybe get as many as 10 recruits for a study – we had 59,” says Dr. Anthony Traboulsee, associate professor in the University of British Columbia Department of Medicine (Neurology) and director of the UBC Hospital MS and NMO Clinic.